about
Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxidesTherapeutic efficacy of nanomedicines for prostate cancer: An updateChemotherapy-enhanced inflammation may lead to the failure of therapy and metastasisMechanisms of Cisplatin nephrotoxicityAn integrated view of cisplatin-induced nephrotoxicity and ototoxicityCisplatin-induced Kidney Dysfunction and Perspectives on Improving Treatment StrategiesQuantitative proteomic and interaction network analysis of cisplatin resistance in HeLa cellsHistological changes in kidney and liver of rats due to gold (III) compound [Au(en)Cl(2)]ClMitochondrial modulation by Epigallocatechin 3-Gallate ameliorates cisplatin induced renal injury through decreasing oxidative/nitrative stress, inflammation and NF-kB in miceLiquid Chromatography Electrospray Ionization Tandem Mass Spectrometric (LC/ESI-MS/MS) Study for the Identification and Characterization of In Vivo Metabolites of Cisplatin in Rat Kidney Cancer Tissues: Online Hydrogen/Deuterium (H/D) Exchange StudyAdditive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARsTissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in ratsEndoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus facesZebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery.N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.Adverse event profiles of platinum agents: data mining of the public version of the FDA adverse event reporting system, AERS, and reproducibility of clinical observations.Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2).Glutamyl aminopeptidase in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats.The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo.Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments.Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin.Effect of glutathione combined with cisplatin and oxaliplatin on the proliferation and apoptosis of lung carcinoma cell line.Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy.Urinary chemokine (C-C motif) ligand 2 (monocyte chemotactic protein-1) as a tubular injury marker for early detection of cisplatin-induced nephrotoxicity.Comparison of the course of biomarker changes and kidney injury in a rat model of drug-induced acute kidney injury.Testicular cancer survivorship: research strategies and recommendations.Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stressCisplatin in cancer therapy: molecular mechanisms of actionEpigallocatechin-3-gallate protects against cisplatin nephrotoxicity by inhibiting the apoptosis in mouse.Multiple analytical approaches demonstrate a complex relationship of genetic and nongenetic factors with cisplatin- and carboplatin-induced nephrotoxicity in lung cancer patientsEvaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.Comparison of caspase-3 activation in tumor cells upon treatment of chemotherapeutic drugs using capillary electrophoresis.Long-term aerobic exercise protects against cisplatin-induced nephrotoxicity by modulating the expression of IL-6 and HO-1.Tempol, a superoxide dismutase mimetic agent, ameliorates cisplatin-induced nephrotoxicity through alleviation of mitochondrial dysfunction in miceAged garlic extract protects against oxidative stress and renal changes in cisplatin-treated adult male rats.Nanocarriers for delivery of platinum anticancer drugs.Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model.Computational modeling of apoptotic signaling pathways induced by cisplatinOptimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status.Loss of α(E)-catenin potentiates cisplatin-induced nephrotoxicity via increasing apoptosis in renal tubular epithelial cells
P2860
Q21203554-EFA88A4D-7C84-48DC-8E23-BF694FA993DCQ26766305-1CE6FEAF-552E-4D93-87AB-CD10E6C697C1Q26858839-A960F3C6-9ACE-4D3A-9EDC-D46DB7B5181BQ26996320-28AB64A0-D6AF-4C38-AF13-4E537EA48BA4Q28080615-A3D625FE-FDF2-41ED-92B3-9E92DA31E81AQ28080842-AE135EC7-2B33-4DE0-8A2E-EA810983052CQ28478299-F0B86E71-C1BD-4FB4-B10C-727ACDD2A60AQ28484603-4A75B3B2-0758-43DA-BA2C-635685AF97C3Q28546437-FD88D2FE-91BF-41A3-81D0-45654DE580B4Q28547006-8CB28FAE-3906-4B70-8C21-D75C2F95F4E0Q28550672-29C2CEC6-3816-448D-AEF1-0B75B494D3E5Q28572929-CCF6229F-52D7-4543-A1A4-886A321AA5E7Q30039723-49EC30F6-FD76-4121-A1FF-7136AD4C6543Q30487697-5B49FB66-C30C-45F9-9DFA-2E27C2366598Q30603357-D09A99CA-223F-4A64-8ED3-178DFF9819CBQ33397057-CD7B67DA-597D-4A4A-8D87-C826F442C547Q33523365-8F6EB17B-F876-4595-A784-7126E1DB4480Q33554447-CC7A8FCD-7A8E-40C2-BA3A-2134BDEEB204Q33620539-2A20E811-BAC3-4D1E-A6FC-7985B6FD70ECQ33645678-5FCBF2EC-78B5-40A8-B13F-9E660C982410Q33661304-4EB7A280-59D7-4006-B64B-85E1A4E607F2Q33693186-F4536016-D49E-4701-BF6E-E53E04A91B2BQ33827802-E59043AA-4AFB-415E-951F-BCB677371570Q33828918-9BE6EE67-2440-4A21-9F2A-D90F24D2DC88Q34033853-43AD5517-B97F-4254-8EEE-8E675C800922Q34039684-D850F415-9875-4685-82B4-CD32B5AD0B1AQ34064560-78917624-9286-4637-AF17-AC7D4084BE79Q34098163-54381247-1DA4-4DEC-834B-8E1B2F0AF27BQ34121293-44B301A7-7FCE-4F60-912E-4F541635015FQ34177673-991BFB12-34B1-4CB1-A1C4-D2222EB20A6EQ34227661-C1131956-1ACC-43A6-BFAB-F620E0E7A6DAQ34243306-5C87682E-1DC6-4320-A763-1E6F3404FE89Q34278172-783ADB27-1948-4651-B0A1-454AA697196AQ34278299-6AFF556F-486D-49A7-937F-80562ECDBAC7Q34304089-EED5B1B6-C960-44D9-8F5E-E93F29D06320Q34338695-570EF02E-D2B4-4B96-94F5-E5D5FDC44E16Q34346562-06637CEF-1138-478A-B14B-7F5CAC4EF2BFQ34411477-645E4D5E-013C-43EC-ADC9-F85D7112552AQ34587489-5CAE39E2-D602-4D78-95D6-F97110F437B5Q34737102-8288E3FF-7880-4750-8BAC-8C811A35C74A
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cisplatin nephrotoxicity: a review.
@en
type
label
Cisplatin nephrotoxicity: a review.
@en
prefLabel
Cisplatin nephrotoxicity: a review.
@en
P2093
P1476
Cisplatin nephrotoxicity: a review.
@en
P2093
Kenneth Nugent
Kessarin Panichpisal
Neil Kurtzman
P304
P356
10.1097/MAJ.0B013E31812DFE1E
P407
P577
2007-08-01T00:00:00Z